title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
"Hypertension Market to Accelerate Positively, Estimates DelveInsight | Key Companies Active in the Market - Novartis, Bayer, Merck, Insmed, Acceleron, AbbVie, Alnylam, Apnimed, AstraZeneca, Gossamer Bio",20230719T210100,https://www.prnewswire.com/news-releases/hypertension-market-to-accelerate-positively-estimates-delveinsight--key-companies-active-in-the-market---novartis-bayer-merck-insmed-acceleron-abbvie-alnylam--apnimed-astrazeneca-gossamer-bio-301880558.html,JWCTF,0.024801,Neutral,-0.004523
Host Hotels & Resorts  ( HST )  Q2 2022 Earnings Call Transcript,20220804T180039,https://www.fool.com/earnings/call-transcripts/2022/08/04/host-hotels-resorts-hst-q2-2022-earnings-call-tran/,JWCTF,0.011089,Neutral,0.092415
Betting In Pickleball Has Arrived - A Guide And Some Observations,20230927T174431,https://www.forbes.com/sites/toddboss/2023/09/27/betting-in-pickleball-has-arriveda-guide-and-some-observations/,JWCTF,0.030779,Neutral,0.055656
"CAR T-cell Therapy for Multiple Myeloma Market to Observe Stunning Growth by 2032, Evaluates DelveInsight | Key Companies - Cartesian, Arcellx, Novartis, Bristol-Myers Squibb, CARsgen, Poseida, Juno, CRISPR, bluebird bio",20230925T210100,https://www.prnewswire.com/news-releases/car-t-cell-therapy-for-multiple-myeloma-market-to-observe-stunning-growth-by-2032-evaluates-delveinsight--key-companies---cartesian-arcellx-novartis-bristol-myers-squibb-carsgen-poseida-juno-crispr-bluebird-bio-301937157.html,JWCTF,0.018757,Neutral,0.012868
